Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America
Given its simplicity and high specificity for distinguishing patients with FCS from MCS, the NAFCS Score could be used in lieu of - or while awaiting - genetic testing to optimize treatment.
Authors
- Eunice Chang (ORCID: https://orcid.org/0000-0003-0177-6153)
- Daniel Soffer (ORCID: https://orcid.org/0000-0001-7681-6303)
- Michael Miller (ORCID: https://orcid.org/0000-0002-1679-2095)
- Michael S. Broder (ORCID: https://orcid.org/0000-0002-2049-5536)
- Alan Chait
- Steven D. Freedman
- Zahid Ahmad (ORCID: https://orcid.org/0000-0002-7810-4024)
- Ambika P. Ashraf (ORCID: https://orcid.org/0000-0003-0692-6624)
- Robert A. Hegele (ORCID: https://orcid.org/0000-0003-2861-5325)
- Nivedita Patni (ORCID: https://orcid.org/0000-0002-5926-7784)
- Sarah N. Gibbs (ORCID: https://orcid.org/0000-0002-1215-642X)
- Irina Yermilov (ORCID: https://orcid.org/0000-0001-6035-2815)
- Brenda Kohn (ORCID: https://orcid.org/0000-0002-4179-7402)
- Cynthia Campos (ORCID: https://orcid.org/0000-0003-2277-0068)
- Jian Wang (ORCID: https://orcid.org/0000-0002-6759-0522)
- Alan S. Brown (ORCID: https://orcid.org/0000-0001-6445-2821)
- Andrew Baldassarra
Institutions
- Western University (CA)
- Beth Israel Deaconess Medical Center (US)
- Hess (United States) (US)
- University of Washington (US)
- Advocate Lutheran General Hospital (US)
- Advocate Good Samaritan Hospital (US)
- University of Alabama at Birmingham (US)
- Southwestern Medical Center (US)
- Philadelphia VA Medical Center (US)
- Kent Optronics (United States) (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1016/j.jacl.2024.09.008
- Citations
- 25
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 10.05
Funders
- Ionis Pharmaceuticals